Search Results - Yongqin Zheng

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Canagliflozin protects cardiovascular function in type 2 diabetic coronary artery disease by regulating natriuretic peptide B

    Canagliflozin protects cardiovascular function in type 2 diabetic coronary artery disease by regulating natriuretic peptide B by Jiarui Zhang, Lichenlu Huang, Yongqin Zheng, Ji Yang, Xiaopei Wu, Jundong He

    Published 2025-08-01

    ABSTRACT Background Canagliflozin (Cana) has protected against diabetes‐related cardiovascular disease. This study was intended to explore the effect and molecular mechanism of Cana on cardiovascular protection in type 2 diabetic coronary atherosclerotic heart disease (CAD). Materials and Methods We...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: